Unknown

Dataset Information

0

Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation.


ABSTRACT: Preclinical studies demonstrate that rapid acting antidepressants, including ketamine require stimulation of mTORC1 signaling. This pathway is regulated by neuronal activity, endocrine and metabolic signals, notably the amino acid leucine, which activates mTORC1 signaling via binding to the upstream regulator sestrin. Here, we examined the antidepressant actions of NV-5138, a novel highly selective small molecule modulator of sestrin that penetrates the blood brain barrier. The results demonstrate that a single dose of NV-5138 produced rapid and long-lasting antidepressant effects, and rapidly reversed anhedonia caused by chronic stress exposure. The antidepressant actions of NV-5138 required BDNF release as the behavioral responses are blocked by infusion of a BDNF neutralizing antibody into the medial prefrontal cortex (mPFC) or in mice with a knock-in of a BDNF polymorphism that blocks activity dependent BDNF release. NV-5138 administration also rapidly increased synapse number and function in the mPFC, and reversed the synaptic deficits caused by chronic stress. Together, the results demonstrate that NV-5138 produced rapid synaptic and antidepressant behavioral responses via activation of the mTORC1 pathway and BDNF signaling, indicating that pharmacological modulation of sestrin is a novel approach for development of rapid acting antidepressants.

SUBMITTER: Kato T 

PROVIDER: S-EPMC6546461 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation.

Kato Taro T   Pothula Santosh S   Liu Rong-Jian RJ   Duman Catharine H CH   Terwilliger Rosemarie R   Vlasuk George P GP   Saiah Eddine E   Hahm Seung S   Duman Ronald S RS  

The Journal of clinical investigation 20190416 6


Preclinical studies demonstrate that rapid acting antidepressants, including ketamine require stimulation of mTORC1 signaling. This pathway is regulated by neuronal activity, endocrine and metabolic signals, notably the amino acid leucine, which activates mTORC1 signaling via binding to the upstream regulator sestrin. Here, we examined the antidepressant actions of NV-5138, a novel highly selective small molecule modulator of sestrin that penetrates the blood brain barrier. The results demonstra  ...[more]

Similar Datasets

| S-EPMC6898593 | biostudies-literature
| S-EPMC5564770 | biostudies-other
| S-EPMC6412019 | biostudies-literature
| S-EPMC4375082 | biostudies-literature
| S-EPMC6333924 | biostudies-literature
| S-EPMC4966330 | biostudies-literature
| S-EPMC5437877 | biostudies-other
| S-EPMC5115827 | biostudies-literature
| S-EPMC5458345 | biostudies-literature
| S-EPMC5478686 | biostudies-literature